Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ferrocin is a homeopathic formulation developed and manufactured by Hapdco Lifesciences. It is marketed in various forms, including syrups, drops, and tablets, and is indicated for the symptomatic relief of various types of fever, common cold, influenza, and coryza. The formulation contains a blend of homeopathic ingredients, including Acetanilidum, Bryonia alba, Rhus toxicodendron, Gelsemium sempervirens, Belladonna, Eupatorium perfoliatum, Andrographis paniculata, Vitex trifoliata, Ferrum phosphoricum, Allium cepa, Ocimum sanctum, and Justicia adhatoda. These components work synergistically to alleviate symptoms such as elevated body temperature, body aches, sore throat, sneezing, and nasal discharge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Ferrocin.